EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticancer Effects of Withanolides: In Silico Prediction of Pharmacological Properties

Gustavo Werneck de Souza E Silva iD, André Mesquita Marques iD, André Luiz Franco Sampaio iD

Molecules · 04.06.2025 · 30 (11) · 2457

DOI: 10.3390/molecules30112457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 04.06.2025. Verfasst von Gustavo Werneck de Souza E Silva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Farmacologia Molecular, Farmanguinhos, Fundação Oswaldo Cruz (FIOCRUZ), Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250…. Hauptthemen laut MEDLINE: Withanolides, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, CNPq PROEPFAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Withanolides are a class of naturally occurring C-28 ergostane steroidal lactones with an abundance of biological activities, and their members are promising candidates for antineoplastic drug development. The ADMET properties of withanolides are still largely unknown, and in silico predictions can play a crucial role highlighting these characteristics for drug development, shortening time and resources spent on the development of a drug lead. In this work, ADMET properties of promising antitumoral withanolides were assessed. Each chemical structure was submitted to the prediction tools: SwissADME, pkCSM–pharmacokinetics, admetSAR v2.0, and Molinspiration Cheminformatics. The results indicate a good gastrointestinal absorption rate, inability to cross the blood–brain barrier, CYP3A4 metabolization, without inhibition of other P450 cytochromes, high interaction with nuclear receptors, and a low toxicity. It was also predicted for the inhibition of pharmacokinetics transporters and some ecotoxicity. This demonstrates a viability for oral drug development, with low probabilities of side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WithanolidesAntineoplastic AgentsHumansComputer SimulationBlood-Brain BarrierMolecular Structure

Stichwörter der Autor:innen

ADMETcancerdrug developmentnatural productswithaferinwithanolides

Substanzen

WithanolidesAntineoplastic Agents

Autor:innen und Institutionen

  • Laboratório de Farmacologia Molecular, Farmanguinhos, Fundação Oswaldo Cruz (FIOCRUZ), Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250, Brazil.
  • Laboratório de Tecnologia Para Biodiversidade em Saúde/TecBio, Farmanguinhos, Fundação Oswaldo Cruz (FIOCRUZ), Rua Sizenando Nabuco 100, Manguinhos, Rio de Janeiro 21041-250, Brazil.

ORCID-Profile: Gustavo Werneck de Souza E Silva, André Mesquita Marques, André Luiz Franco Sampaio

Förderung

  • National Council for Scientific and Technological Development
  • CNPq PROEPFAR

Zitieren

APA

Silva, G. W. S. E., Marques, A. M., & Sampaio, A. L. F. (2025). Anticancer Effects of Withanolides: In Silico Prediction of Pharmacological Properties. Molecules, 30(11), 2457. https://doi.org/10.3390/molecules30112457

Vancouver

Silva GWSE, Marques AM, Sampaio ALF. Anticancer Effects of Withanolides: In Silico Prediction of Pharmacological Properties. Molecules. 2025;30(11):2457. doi:10.3390/molecules30112457

BibTeX
@article{Silva2025,
  author = {Silva, Gustavo Werneck de Souza E and Marques, André Mesquita and Sampaio, André Luiz Franco},
  title = {Anticancer Effects of Withanolides: In Silico Prediction of Pharmacological Properties},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {11},
  pages = {2457},
  doi = {10.3390/molecules30112457}
}
Kostenlos starten →